Loading chat...
IN SB0161
Bill
AI Summary
SB0161 Summary
-
Requires the division of state court administration to report felony convictions related to methamphetamine manufacturing to the National Precursor Log Exchange (NPLEx) to generate stop sale alerts preventing convicted individuals from purchasing ephedrine or pseudoephedrine.
-
Mandates the Indiana board of pharmacy adopt emergency rules effective July 1, 2016, establishing standards for pharmacist professional judgments and "relationship on record" requirements for ephedrine and pseudoephedrine sales.
-
Authorizes the board to review pharmacist professional determinations regarding ephedrine and pseudoephedrine sales and take disciplinary action against pharmacists who violate applicable rules.
-
Expands the INSPECT prescription monitoring program to include ephedrine and pseudoephedrine tracking with data transmission requirements ranging from 7 days to 24 hours depending on the time period.
-
Declares an emergency for the act's implementation, indicating urgent need for these methamphetamine precursor controls.
Legislative Description
Pharmacists, ephedrine, and methamphetamine. Requires the division of state court administration to report certain methamphetamine-related felonies to the National Precursor Log Exchange (NPLEx) so that NPLEx can generate a stop sale alert to prevent persons convicted of those felonies from purchasing ephedrine or pseudoephedrine. Requires the Indiana board of pharmacy (board) to adopt emergency rules that are effective July 1, 2016, concerning: (1) professional determinations made; and (2) a relationship on record with the pharmacy; concerning the sale of ephedrine or pseudoephedrine. Authorizes the board to: (1) review professional determinations made; and (2) discipline a pharmacist who violates a rule
Last Action
Public Law 5
3/21/2016